Cargando…

Trimethylamine N-Oxide, a Gut Microbiota-Dependent Metabolite, is Associated with Frailty in Older Adults with Cardiovascular Disease

OBJECTIVE: Our study aimed to explore the association between trimethylamine N-oxide and frailty in older adults with cardiovascular disease. PATIENTS AND METHODS: This cross-sectional study analyzed a total of 451 people aged 65 years or older who underwent comprehensive geriatric assessments. Frai...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Wei, Luo, Yao, Liu, Jun-Peng, Sun, Ning, Guo, Di, Cui, Ling-Ling, Zheng, Pei-Pei, Yao, Si-Min, Yang, Jie-Fu, Wang, Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7534046/ https://www.ncbi.nlm.nih.gov/pubmed/33061331 http://dx.doi.org/10.2147/CIA.S270887

Ejemplares similares

Trimethylamine N-Oxide, a Gut Microbiota-Dependent Metabolite, is Associated with Frailty in Older Adults with Cardiovascular Disease [Corrigendum]
Publicado: (2021)

Association of Gut Microbiota-Dependent Metabolite Trimethylamine N-Oxide with First Ischemic Stroke
por: Sun, Taoping, et al.
Publicado: (2021)

The gut microbial metabolite trimethylamine N-oxide and cardiovascular diseases
por: Zhen, Jing, et al.
Publicado: (2023)

Gut microbiota dependant trimethylamine N-oxide and hypertension
por: Mutengo, Katongo H., et al.
Publicado: (2023)

Gut Microbiota-Dependent Trimethylamine N-Oxide Pathway Associated with Cardiovascular Risk in Children with Early-Stage Chronic Kidney Disease
por: Hsu, Chien-Ning, et al.
Publicado: (2018)

Association of Trimethylamine, Trimethylamine N-oxide, and Dimethylamine with Cardiovascular Risk in Children with Chronic Kidney Disease
por: Hsu, Chien-Ning, et al.
Publicado: (2020)

The gut microbiota-derived metabolite trimethylamine N-oxide is elevated in Alzheimer’s disease
por: Vogt, Nicholas M., et al.
Publicado: (2018)

Elevation of the Gut Microbiota Metabolite Trimethylamine N-Oxide Predicts Stroke Outcome
por: Nam, Hyo Suk, et al.
Publicado: (2019)

It's a “Gut Feeling”: Association of Microbiota, Trimethylamine N‐Oxide and Cardiovascular Outcomes
por: Kolluru, Gopi K., et al.
Publicado: (2020)

A Novel Trimethylamine Oxide-Induced Model Implicates Gut Microbiota-Related Mechanisms in Frailty
por: Chen, Si-yue, et al.
Publicado: (2022)

Association Between Frailty and Gut Microbiota Metabolite TMAO in Older People With Cardiovascular Disease
por: He, Wei, et al.
Publicado: (2020)

Gut Microbiota-Dependent Metabolite Trimethylamine N-Oxide Contributes to Cardiac Dysfunction in Western Diet-Induced Obese Mice
por: Chen, Kui, et al.
Publicado: (2017)

High-circulating gut microbiota-dependent metabolite trimethylamine N-oxide is associated with poor prognosis in pulmonary arterial hypertension
por: Yang, Yicheng, et al.
Publicado: (2022)

Gut microbiota-derived metabolite trimethylamine-N-oxide and stroke outcome: a systematic review
por: Zhang, Peng, et al.
Publicado: (2023)

Gut microbiota dependent trimethylamine N-oxide aggravates angiotensin II–induced hypertension
por: Jiang, Shan, et al.
Publicado: (2021)

Metabolic retroconversion of trimethylamine N-oxide and the gut microbiota
por: Hoyles, Lesley, et al.
Publicado: (2018)

Gut microbiota in atherosclerosis: focus on trimethylamine N‐oxide
por: Zhu, Yingqian, et al.
Publicado: (2020)

Gut microbiota-dependent metabolite trimethylamine N-oxide (TMAO) and cardiovascular risk in patients with suspected functionally relevant coronary artery disease (fCAD)
por: Amrein, Melissa, et al.
Publicado: (2022)

Trimethylamine N-oxide, a gut microbiota-dependent metabolite of choline, is positively associated with the risk of primary liver cancer: a case-control study
por: Liu, Zhao-Yan, et al.
Publicado: (2018)

Gut Microbiota-Dependent Trimethylamine N-Oxide Associates With Inflammation in Common Variable Immunodeficiency
por: Macpherson, Magnhild E., et al.
Publicado: (2020)

Trimethylamine N-Oxide, a Gut Microbiota-Derived Metabolite, Is Associated with Cardiovascular Risk in Psoriasis: A Cross-Sectional Pilot Study
por: Sikora, Mariusz, et al.
Publicado: (2021)

Association of Trimethylamine N-Oxide and Metabolites With Mortality in Older Adults
por: Fretts, Amanda M., et al.
Publicado: (2022)

Gut Microbiota and Ischemic Stroke: The Role of Trimethylamine N-Oxide
por: Nam, Hyo Suk
Publicado: (2019)

Gut Metabolite Trimethylamine-N-Oxide in Atherosclerosis: From Mechanism to Therapy
por: Wang, BingYu, et al.
Publicado: (2021)

Dynamic Changes and Prognostic Value of Gut Microbiota-Dependent Trimethylamine-N-Oxide in Acute Ischemic Stroke
por: Tan, Chuhong, et al.
Publicado: (2020)

Associations of gut-flora-dependent metabolite trimethylamine-N-oxide, betaine and choline with non-alcoholic fatty liver disease in adults
por: Chen, Yu-ming, et al.
Publicado: (2016)

The Gut Microbial Metabolite Trimethylamine-N-Oxide Is Present in Human Cerebrospinal Fluid
por: Rio, Daniele Del, et al.
Publicado: (2017)

Atherosclerosis amelioration by allicin in raw garlic through gut microbiota and trimethylamine-N-oxide modulation
por: Panyod, Suraphan, et al.
Publicado: (2022)

Gut microbe-derived metabolite trimethylamine N-oxide activates PERK to drive fibrogenic mesenchymal differentiation
por: Kim, Seok-Jo, et al.
Publicado: (2022)

Gut microbiota-generated metabolite, trimethylamine-N-oxide, and subclinical myocardial damage: a multicenter study from Thailand
por: Senthong, Vichai, et al.
Publicado: (2021)

Gut microbiota–derived metabolite trimethylamine-N-oxide and multiple health outcomes: an umbrella review and updated meta-analysis
por: Li, Doudou, et al.
Publicado: (2022)

Microbiota-dependent metabolite and cardiovascular disease marker trimethylamine-N-oxide (TMAO) is associated with monocyte activation but not platelet function in untreated HIV infection
por: Haissman, Judith M., et al.
Publicado: (2017)

Gut Microbiota-Dependent Trimethylamine-N-oxide and Serum Biomarkers in Patients with T2DM and Advanced CKD
por: Al-Obaide, Mohammed A. I., et al.
Publicado: (2017)

Association of Choline Intake with Blood Pressure and Effects of Its Microbiota-Dependent Metabolite Trimethylamine-N-Oxide on Hypertension
por: He, Guo-dong, et al.
Publicado: (2022)

Paradox of trimethylamine-N-oxide, the impact of malnutrition on microbiota-derived metabolites and septic patients
por: Chou, Ruey-Hsing, et al.
Publicado: (2021)

The Gut Microbial Metabolite Trimethylamine N-Oxide is Linked to Specific Complications of Systemic Sclerosis
por: Stec, Albert, et al.
Publicado: (2023)

Gut microbiota-associated metabolite trimethylamine N-Oxide and the risk of stroke: a systematic review and dose–response meta-analysis
por: Farhangi, Mahdieh Abbasalizad, et al.
Publicado: (2020)

The role of gut microbiota metabolite trimethylamine N-oxide in functional impairment of bone marrow mesenchymal stem cells in osteoporosis disease
por: Lin, Hao, et al.
Publicado: (2020)

Gut microbiota-dependent trimethylamine n-oxide pathway contributes to the bidirectional relationship between intestinal inflammation and periodontitis
por: Wang, Qiqi, et al.
Publicado: (2023)

Uncovering the trimethylamine-producing bacteria of the human gut microbiota
por: Rath, Silke, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_n6vbnuceics8jj22357ggh312c